FB
ALNY icon

Fulton Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Fulton Bank’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$453K Sell
1,505
-44
-3% -$13.3K 0.01% 509
2026
Q1 		$513K Buy
1,549
+119
+8% +$40.5K 0.02% 440
2025
Q4 		$569K Sell
1,430
-114
-7% -$50.5K 0.02% 417
2025
Q3 		$704K Buy
1,544
+123
+9% +$50.1K 0.02% 364
2025
Q2 		$463K Buy
1,421
+46
+3% +$12.7K 0.02% 444
2025
Q1 		$371K Buy
1,375
+32
+2% +$8.22K 0.02% 479
2024
Q4 		$316K Buy
1,343
+301
+29% +$79.2K 0.01% 530
2024
Q3 		$287K Buy
1,042
+24
+2% +$6.25K 0.01% 557
2024
Q2 		$247K Buy
+1,018
New +$161K 0.01% 564

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fulton Bank's ALNY Position: Q2 2026 in Review

Fulton Bank reduced its Alnylam Pharmaceuticals (ALNY) stake by 2.8% in Q2 2026, selling an estimated $13.3K and leaving 1,505 shares worth $453K. The position accounts for 0.01% of the portfolio, ranked #509.

Fulton Bank first reported a position in ALNY in Q2 2024 and has held it in 9 quarters since. The position peaked at $704K in Q3 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Fulton Bank held 1,505 shares of Alnylam Pharmaceuticals worth $453K as of Q2 2026.
  • Fulton Bank sold 44 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $13.3K.
  • Alnylam Pharmaceuticals made up 0.01% of Fulton Bank's portfolio in Q2 2026, its #509 holding.
  • Fulton Bank first reported a position in Alnylam Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Fulton Bank's Alnylam Pharmaceuticals position peaked at $704K in Q3 2025.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.